On 18 May 2025, at the American Thoracic Society International Conference, held in San Francisco, California, post hoc findings from the Phase IIa COURSE trial (NCT04039113) shed light on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback